🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eric Larsen

University of Massachusetts Chan Medical School

ORCID: 0000-0002-4783-5975

Also affiliated with New England Cancer Specialists

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation”.

Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation

Journal of Clinical Oncology(2021)10.1200/jco.20.03286

N/A

2.4DataRank · unranked

59 citations

Michael P. Link, Amy L. Billett, Jamie E. Flerlage, John T. Lucas, Belinda N. Mandrell +16 more

Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2024)10.1200/jco.23.02238

N/A

1.2DataRank · unranked

58 citations

Wenan Chen, Chunxu Qu, Zhongshan Cheng, Dale J. Hedges, Abdelrahman Elsayed +32 more

Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2021)10.1002/pbc.28913

N/A

0DataRank · unranked

14 citations

Julie Baran, Robert B. Noll, Victoria W. Willard, Kristina K. Hardy, Leanne Embry +5 more

Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2241

N/A

0DataRank · unranked

13 citations

Wenjian Yang, Colton A. Smith, Cheng Cheng, Seth E. Karol, Eric Larsen +15 more

Minimal residual disease at end of induction and consolidation remain important prognostic indicators for newly diagnosed children and young adults with very high-risk (VHR) B-lymphoblastic leukemia (B-ALL): Children’s Oncology Group AALL1131.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10004

N/A

0DataRank · unranked

4 citations

Michael J. Burke, Meenakshi Devidas, Yunfeng Dai, Nyla A. Heerema, Andrew J. Carroll +11 more

ZNF146/OZF and ZNF507 target LINE-1 sequences

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.24.445350

N/A

0DataRank · unranked

0 citations

Eric Larsen, Jeanne B. Lawrence, Kevin M. Creamer

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia

Blood Advances(2022)10.1182/bloodadvances.2022008563

N/A

0DataRank · unranked

17 citations

Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T. Teachey +13 more

ZNF146/OZF and ZNF507 target LINE-1 sequences

G3 Genes Genomes Genetics(2022)10.1093/g3journal/jkac002

N/A

0DataRank · unranked

4 citations

Eric Larsen, Jeanne B. Lawrence, Kevin M. Creamer

Effects of age, obesity, and body surface area on asparaginase-associated toxicities during acute lymphoblastic leukemia induction therapy: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7000

N/A

0DataRank · unranked

6 citations

Olga Militano, Zhiguo Chen, Meenakshi Devidas, Luke Maese, Rachel E. Rau +13 more

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials

The Lancet Haematology(2023)10.1016/s2352-3026(22)00371-4

N/A

0DataRank · unranked

68 citations

Yunfeng Dai, Zhiguo Chen, Lena E. Winestone, David T. Teachey, Kira Bona +26 more

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children

Research Square(2023)10.21203/rs.3.rs-3171814/v1

N/A

0DataRank · unranked

2 citations

Carolin Escherich, Wenan Chen, Yizhen Li, Wenjian Yang, Rina Nishii +13 more

Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study

Leukemia(2024)10.1038/s41375-024-02395-4

N/A

0DataRank · unranked

68 citations

Deepa Bhojwani, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, John A. Kairalla +25 more

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report

Leukemia(2024)10.1038/s41375-024-02166-1

N/A

0DataRank · unranked

22 citations

Mignon L. Loh, Michael J. Borowitz, Sumit Gupta, Karen R. Rabin, Patrick A. Zweidler‐McKay +26 more

Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia

Research Square(2024)10.21203/rs.3.rs-5292018/v1

N/A

0DataRank · unranked

3 citations

Emily Ashcraft, Ti‐Cheng Chang, Kathryn G. Roberts, Samuel W. Brady, Yiping Fan +22 more

Association ofGATA3Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa138

N/A

0DataRank · unranked

23 citations

Anthony Pak‐Yin Liu, Meenakshi Devidas, Shawn HR Lee, Xueyuan Cao, Deqing Pei +21 more

Selective chr21 homolog silencing reveals polymorphisms influence the epigenetic silencing and functional dosage of RWDD2B

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.17.676855

N/A

0DataRank · unranked

0 citations

Jennifer Moon, Oliver D. King, Jeanne B. Lawrence, Eric Larsen

Outcomes in children with Down syndrome (DS) and B-lymphoblastic leukemia (B-ALL): A Children’s Oncology Group (COG) report.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10510

N/A

0DataRank · unranked

7 citations

Zhiguo Chen, Meenakshi Devidas, Johann Hitzler, Eric Larsen, Michael J. Burke +14 more